American Society of Addiction Medicine
Shawn McNeil, MD
Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder
Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder
Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder
Wednesday 3rd January 2018
Dr. Sarah Bagley discusses combating stigma in medication treatment for adolescents with opioid use disorder. Listen now for insights and future visions.
11 minutes
Informative
Empowering
Hopeful
Encouraging
Thought-provoking
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
35 (View all)
Do you want to link to this podcast?
Get the buttons here!Breaking Barriers: Treating Adolescents with Opioid Use Disorder
As we started to talk among ourselves and the team and then talking to other providers in the community, we realized that this was a common theme and was something that we should write about, so that people start to think about how can we address the stigma that's actually associated not with just having the disease of an opioid use disorder, but actually around the treatment as well.
Imagine facing the challenge of treating adolescents with opioid use disorder while battling the stigma that surrounds medication treatments. Dr. Sarah Bagley, assistant professor at Boston University School of Medicine and medical director of the Catalyst Program at Boston Medical Center, takes on this issue head-on in this compelling episode of 'Addiction Medicine: Beyond the Abstract'. She dives into the misconceptions that often come from well-meaning but uninformed individuals and emphasizes the power of language and education in changing perceptions.
Dr. Bagley sheds light on the recent policy statement by the American Academy of Pediatrics, which advocates for using medications like buprenorphine/naloxone, methadone, and naltrexone for adolescents with moderate to severe opioid use disorder. This policy aligns pediatricians with addiction professionals, marking a significant shift towards early intervention and comprehensive care. Dr. Bagley also shares her vision for the future, highlighting the need for more trained physicians and robust pediatric treatment programs.
Tune in to understand how breaking down these barriers can lead to better outcomes for young patients struggling with addiction.